Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

SIGA Technologies

Biotech & Life Sciences · New York City, United States · Founded 1995 · IPO 1997 Thoroughbred

Specializes in developing therapeutic solutions for some of the most lethal pathogens – smallpox

Valuation
$176M
Market cap · May/2026
Revenue
$95M
Latest reported FY
EBITDA
$3.2M
Latest reported FY

Global footprint

Where SIGA Technologies has talent and traffic

Workforce by country
4 countries with
team presence
🇺🇸 United States92.5%
🇧🇩 Bangladesh2.5%
🇧🇷 Brazil2.5%
🇨🇿 Czech Republic2.5%
4 countries shown
Web traffic by country
8.6K monthly visits
across markets
🇺🇸 United States66.3%
🇮🇳 India31.4%
🇬🇧 United Kingdom3.5%
Top 3 markets shown

Market sentiment

What the market is saying about SIGA Technologies

An AI-synthesized read of the highest-engagement posts about SIGA Technologies on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See SIGA Technologies on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.